Moreover, FAC-treated leukaemia cells displayed a significant inhibition of total and active NRF2 levels in Molt-4 cells (Figure 4h and Figure S2d), as well as the inhibition of total and acetylated (Lys599) NRF2 levels in Sup-B15 cells (Figure 4i and Figure S2e). The gene discussed is NFE2L2; the disease is leukemia.